Balyasny Asset Management’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.65M | Buy |
+488,498
| New | +$4.65M | 0.01% | 921 |
|
2025
Q1 | – | Sell |
-169,306
| Closed | -$3.99M | – | 2100 |
|
2024
Q4 | $3.99M | Sell |
169,306
-75,804
| -31% | -$1.79M | 0.01% | 916 |
|
2024
Q3 | $8.8M | Buy |
+245,110
| New | +$8.8M | 0.01% | 711 |
|
2023
Q4 | – | Sell |
-17,646
| Closed | -$158K | – | 1996 |
|
2023
Q3 | $158K | Buy |
+17,646
| New | +$158K | ﹤0.01% | 1589 |
|
2022
Q3 | – | Sell |
-98,866
| Closed | -$679K | – | 2433 |
|
2022
Q2 | $679K | Buy |
+98,866
| New | +$679K | ﹤0.01% | 1497 |
|
2021
Q3 | – | Sell |
-195,052
| Closed | -$4.1M | – | 1764 |
|
2021
Q2 | $4.1M | Buy |
+195,052
| New | +$4.1M | 0.02% | 687 |
|